Orlando, FL -- (SBWIRE) -- 10/28/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Dendreon Corporation (NASDAQ:DNDN), MannKind Corporation (NASDAQ:MNKD).
Dendreon Corporation (NASDAQ:DNDN) shares climbed 4.98% to $2.53. The company announced that management will host a conference call on Tuesday, November 12, 2013, at 9:00 a.m. EST to review third quarter financial results.
Additionally, the company on Sept. 27 announced the presentation of data from clinical studies featuring PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for metastatic castrate-resistant prostate cancer (mCRPC), at the 2013 European Cancer Congress in Amsterdam, September 27-October 1, 2013.
Are investors worried about the recent updates with DNDN? Find out with a free trend analysis HERE
MannKind Corporation (NASDAQ:MNKD) shares declined 2.47% to $5.32. The company on Oct. 14 announced the resubmission on October 13, 2013 of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder with an indication to improve glycemic control in adults with type 1 or type 2 diabetes. The resubmission is based on the entire data set from the extensive AFREZZA clinical development program and particularly the positive results from two recent Phase 3 trials, one in patients with type 1 diabetes (study 171) and one in patients with type 2 diabetes (study 175).
Additionally, Zacks restated their neutral rating on shares of MNKD in a research note issued to investors on Oct. 17. The firm currently has a $5.50 price target on the stock.
Is MNKD going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)